Invention Grant
![Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof](/docs/US/2024-07-02/US12024511B2/abs.jpg.600x600.jpg)
- Patent Title: Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof
-
Application No.: US16984110Application Date: 2020-08-03
-
Publication No.: US12024511B2Publication Date: 2024-07-02
- Inventor: Jin Li , Shung Wu , Minmin Yang , Sean Chen , Wenshan Hao
- Applicant: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Applicant Address: CN Shanghai
- Assignee: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Current Assignee: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
- Current Assignee Address: CN Shanghai
- Agency: Juniv LLP
- Agent Lin Yu, Esq.
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K9/00 ; A61K9/10 ; A61K31/437 ; A61K31/4545 ; A61K31/496 ; A61K31/5377 ; A61K31/541 ; A61K45/06 ; A61K47/10 ; A61K47/38 ; C07D487/04
![Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof](/abs-image/US/2024/07/02/US12024511B2/abs.jpg.150x150.jpg)
Abstract:
Provided herein are substituted imidazo[1,2-a]pyridin-2-ylamine compounds, for example, of formula (A), and pharmaceutical compositions thereof; and methods of their use for treating, preventing, or ameliorating one or more symptoms of a Janus kinase-mediated disease.
Information query
